Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,735 | 234 | 92.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $348.41 | 2 | 6.8% |
| Education | $32.78 | 3 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,009 | 22 | $0 (2020) |
| Novo Nordisk Inc | $686.02 | 42 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $461.47 | 21 | $0 (2021) |
| Abbott Laboratories | $396.49 | 5 | $0 (2021) |
| GlaxoSmithKline, LLC. | $259.48 | 20 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $252.09 | 14 | $0 (2019) |
| Allergan, Inc. | $246.95 | 19 | $0 (2020) |
| Lilly USA, LLC | $197.99 | 18 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $191.59 | 11 | $0 (2018) |
| Romark Laboratories, LC | $182.11 | 10 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $125.00 | 1 | Vifor Pharma, Inc. ($125.00) |
| 2022 | $124.99 | 2 | OptiNose US, Inc. ($124.99) |
| 2021 | $150.50 | 8 | Novo Nordisk Inc ($64.19) |
| 2020 | $438.46 | 16 | Abbott Laboratories ($201.70) |
| 2019 | $1,249 | 53 | AstraZeneca Pharmaceuticals LP ($283.03) |
| 2018 | $1,497 | 70 | AstraZeneca Pharmaceuticals LP ($382.02) |
| 2017 | $1,532 | 89 | AstraZeneca Pharmaceuticals LP ($314.03) |
All Payment Transactions
239 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/02/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Hyperkalemia | ||||||
| 06/08/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $113.63 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 06/08/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 05/26/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Diabetes | ||||||
| 04/27/2021 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 04/21/2021 | Amgen Inc. | — | Education | In-kind items and services | $13.89 | General |
| 04/13/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Diabetes | ||||||
| 03/15/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: Diabetes | ||||||
| 03/04/2021 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Diabetes Care | ||||||
| 02/23/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2020 | Romark Laboratories, LC | ALINIA (Drug), ALINIA, ALINIA | Food and Beverage | In-kind items and services | $28.89 | General |
| Category: Gastroenterology | ||||||
| 12/07/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Diabetes | ||||||
| 11/24/2020 | Romark Laboratories, LC | ALINIA (Drug), ALINIA, ALINIA | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: Gastroenterology | ||||||
| 11/03/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Diabetes | ||||||
| 09/30/2020 | Abbott Laboratories | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $201.70 | General |
| 04/22/2020 | Romark Laboratories, LC | ALINIA (Drug), ALINIA, ALINIA | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: Gastroenterology | ||||||
| 03/19/2020 | Romark Laboratories, LC | ALINIA (Drug), ALINIA, ALINIA | Food and Beverage | In-kind items and services | $8.64 | General |
| Category: Gastroenterology | ||||||
| 03/04/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: NEUROSCIENCE | ||||||
| 02/25/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/12/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/11/2020 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Diabetes | ||||||
| 01/31/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/29/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: NEUROSCIENCE | ||||||
| 01/18/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 533 | 647 | $76,048 | $38,045 |
| 2022 | 11 | 453 | 520 | $50,130 | $28,561 |
| 2021 | 16 | 748 | 904 | $82,973 | $49,638 |
| 2020 | 33 | 1,927 | 2,608 | $191,949 | $86,753 |
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 127 | $19,050 | $9,919 | 52.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 60 | 60 | $10,500 | $7,415 | 70.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 82 | 128 | $14,720 | $6,981 | 47.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 20 | 23 | $7,465 | $4,853 | 65.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 28 | 28 | $2,400 | $2,014 | 83.9% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 12 | 12 | $3,840 | $1,578 | 41.1% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 19 | 19 | $5,705 | $1,105 | 19.4% |
| 97750 | Test or measurement for functional capacity, each 15 minutes | Office | 2023 | 47 | 47 | $2,585 | $984.10 | 38.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 29 | 29 | $1,363 | $855.79 | 62.8% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2023 | 15 | 15 | $2,625 | $754.20 | 28.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 40 | 40 | $2,600 | $703.60 | 27.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 40 | 48 | $720.00 | $403.20 | 56.0% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 12 | 12 | $360.00 | $194.40 | 54.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 14 | $475.00 | $118.47 | 24.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 14 | 14 | $420.00 | $62.30 | 14.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 13 | 17 | $170.00 | $57.97 | 34.1% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 14 | 14 | $1,050 | $47.40 | 4.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 100 | 144 | $21,620 | $12,131 | 56.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 49 | 49 | $8,575 | $6,185 | 72.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 70 | $8,050 | $4,286 | 53.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 42 | 43 | $3,225 | $2,941 | 91.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 42 | 43 | $2,021 | $1,222 | 60.4% |
| 97750 | Test or measurement for functional capacity, each 15 minutes | Office | 2022 | 40 | 40 | $2,200 | $853.06 | 38.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 33 | 33 | $2,145 | $586.44 | 27.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 51 | 60 | $894.00 | $178.26 | 19.9% |
About Dr. Alejandro Fuentes, M.D
Dr. Alejandro Fuentes, M.D is a Family Medicine healthcare provider based in Weslaco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619940475.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alejandro Fuentes, M.D has received a total of $5,116 in payments from pharmaceutical and medical device companies, with $125.00 received in 2024. These payments were reported across 239 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($4,735).
As a Medicare-enrolled provider, Fuentes has provided services to 3,661 Medicare beneficiaries, totaling 4,679 services with total Medicare billing of $202,998. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Weslaco, TX
- Active Since 02/10/2006
- Last Updated 02/29/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1619940475
Products in Payments
- FARXIGA (Drug) $693.12
- BYDUREON (Drug) $274.82
- Tresiba (Drug) $262.29
- Veltassa (Drug) $250.70
- TOUJEO (Drug) $227.85
- Victoza (Drug) $191.58
- SOLIQUA (Drug) $167.77
- Ozempic (Drug) $150.15
- BREO (Drug) $144.70
- STEGLATRO (Drug) $135.94
- XARELTO (Drug) $128.92
- Trulance (Drug) $127.30
- Xhance (Drug) $124.99
- BYSTOLIC (Drug) $124.20
- TRULICITY (Drug) $123.18
- JANUVIA (Drug) $116.15
- ALINIA (Drug) $101.86
- Vascepa (Drug) $98.86
- JARDIANCE (Drug) $92.59
- Alinia (Drug) $80.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Weslaco
Melecia Fuentes, M.d, M.D
Family Medicine — Payments: $7,400
Dr. Donna Mery, M.d, M.D
Family Medicine — Payments: $4,323
Dr. Roger Heredia, M.d, M.D
Family Medicine — Payments: $3,405
Larissa Riojas, Do, DO
Family Medicine — Payments: $3,282
Martha Cano, Md, MD
Family Medicine — Payments: $2,563
Pamela Ramirez Stroman, M.d, M.D
Family Medicine — Payments: $2,176